TITLE

Correction: Neuroprotective Effect of Scutellarin on Ischemic Cerebral Injury by Down-Regulating the Expression of Angiotensin-Converting Enzyme and AT1 Receptor

AUTHOR(S)
Wang, Wenjuan; Ma, Xiaotang; Han, Jichun; Zhou, Mingjie; Ren, Huanhuan; Pan, Qunwen; Zheng, Chunli; Zheng, Qiusheng
PUB. DATE
January 2016
SOURCE
PLoS ONE;1/22/2016, Vol. 11 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Correction Notice
ABSTRACT
No abstract available.
ACCESSION #
112438983

 

Related Articles

  • Expression of angiotensin II and its receptors in activated microglia in experimentally induced cerebral ischemia in the adult rats. Wu, Chun-Yun; Zha, Hao; Xia, Qing-Qing; Yuan, Yun; Liang, Xiao-Yan; Li, Jing-Hui; Guo, Ze-Yun; Li, Juan-Juan // Molecular & Cellular Biochemistry;Oct2013, Vol. 382 Issue 1/2, p47 

    Expression of angiotensin II (Ang II) and its receptors (AT/AT) is undetected in the mature microglia in normal brain. We report here that the immunoexpression of Ang II and AT/AT was altered in activated microglia notably at 1 week in rats subjected to middle cerebral artery occlusion (MCAO)....

  • Neuroprotective Effect of Scutellarin on Ischemic Cerebral Injury by Down-Regulating the Expression of Angiotensin-Converting Enzyme and AT1 Receptor. Wang, Wenjuan; Ma, Xiaotang; Han, Jichun; Zhou, Mingjie; Ren, Huanhuan; Pan, Qunwen; Zheng, Chunli; Zheng, Qiusheng // PLoS ONE;1/5/2016, Vol. 11 Issue 1, p1 

    Background and Purpose: Previous studies have demonstrated that angiotensin-converting enzyme (ACE) is involved in brain ischemic injury. In the present study, we investigated whether Scutellarin (Scu) exerts neuroprotective effects by down-regulating the Expression of Angiotensin-Converting...

  • Vascular Protection by Angiotensin Receptor Antagonism Involves Differential VEGF Expression in Both Hemispheres after Experimental Stroke. Guan, Weihua; Somanath, Payaningal R.; Kozak, Anna; Goc, Anna; El-Remessy, Azza B.; Ergul, Adviye; Johnson, Maribeth H.; Alhusban, Ahmed; Soliman, Sahar; Fagan, Susan C. // PLoS ONE;2011, Vol. 6 Issue 9, p1 

    We identified that the angiotensin receptor antagonist, candesartan, has profound neurovascular protective properties when administered after ischemic stroke and was associated with a proangiogenic state at least partly explained by vascular endothelial growth factor A (VEGFA). However, the...

  • Protective Effect of Luteolin in Experimental Ischemic Stroke: Upregulated SOD1, CAT, Bcl-2 and Claudin-5, Down-Regulated MDA and Bax Expression. Qiao, Huimin; Dong, Lipeng; Zhang, Xiangjian; Zhu, Chunhua; Zhang, Xiaolin; Wang, Lina; Liu, Zongjie; Chen, Linyu; Xing, Yinxue; Wang, Chaohui; Li, Yanhua // Neurochemical Research;Sep2012, Vol. 37 Issue 9, p2014 

    Luteolin recently has been proved to elicit a vanity of biological effects through its antioxidant and anti-apoptosis properties. Oxidative and apoptosis damage play an important role in cerebral ischemic pathogenesis and may represent a target for treatment. The aim of this study was to...

  • Modeling Dynamic Regulatory Processes in Stroke. McDermott, Jason E.; Jarman, Kenneth; Taylor, Ronald; Lancaster, Mary; Shankaran, Harish; Vartanian, Keri B.; Stevens, Susan L.; Stenzel-Poore, Mary P.; Sanfilippo, Antonio // PLoS Computational Biology;Oct2012, Vol. 8 Issue 10, p1 

    The ability to examine the behavior of biological systems in silico has the potential to greatly accelerate the pace of discovery in diseases, such as stroke, where in vivo analysis is time intensive and costly. In this paper we describe an approach for in silico examination of responses of the...

  • Neuroprotective Effect of Inhaled Nitric Oxide on Excitotoxic-Induced Brain Damage in Neonatal Rat. Pansiot, Julien; Loron, Gauthier; Olivier, Paul; Fontaine, Romain; Charriaut-Marlangue, Christiane; Mercier, Jean-Christophe; Gressens, Pierre; Baud, Olivier // PLoS ONE;2010, Vol. 5 Issue 6, p1 

    Background: Inhaled nitric oxide (iNO) is one of the most promising therapies used in neonates. However, little information is known about its impact on the developing brain submitted to excitotoxic challenge. Methodology/Principal Findings: We investigated here the effect of iNO in a neonatal...

  • CpG preconditioning regulates miRNA expression that modulates genomic reprogramming associated with neuroprotection against ischemic injury. Vartanian, Keri B; Mitchell, Hugh D; Stevens, Susan L; Conrad, Valerie K; McDermott, Jason E; Stenzel-Poore, Mary P // Journal of Cerebral Blood Flow & Metabolism;Feb2015, Vol. 35 Issue 2, p257 

    Cytosine-phosphate-guanine (CpG) preconditioning reprograms the genomic response to stroke to protect the brain against ischemic injury. The mechanisms underlying genomic reprogramming are incompletely understood. MicroRNAs (miRNAs) regulate gene expression; however, their role in modulating...

  • The Differentially Expressed Circular RNAs in the Substantia Nigra and Corpus Striatum of Nrf2-Knockout Mice. Yang, Jun-Hui; Zhang, Run-Jiao; Lin, Jia-Jie; Cao, Ming-Chao; Wang, Qie; Cui, Hui-Xian; Sun, Shao-Guang; Wang, Lei // Cellular Physiology & Biochemistry (Karger AG);10/25/2018, Vol. 50 Issue 3, p936 

    Background/Aims: The nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element (ARE) pathway plays a protective role in both acute neuronal damage and chronic neurodegeneration-related oxidative stress. Circular RNAs (circRNAs) are involved with various diseases in the...

  • Pathway Analysis Reveals Common Pro-Survival Mechanisms of Metyrapone and Carbenoxolone after Traumatic Brain Injury. Hellmich, Helen L.; Rojo, Daniel R.; Micci, Maria-Adelaide; Sell, Stacy L.; Boone, Deborah R.; Crookshanks, Jeanna M.; DeWitt, Douglas S.; Masel, Brent E.; Prough, Donald S. // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    Developing new pharmacotherapies for traumatic brain injury (TBI) requires elucidation of the neuroprotective mechanisms of many structurally and functionally diverse compounds. To test our hypothesis that diverse neuroprotective drugs similarly affect common gene targets after TBI, we compared...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics